Indeed, analysis of the cancer genome atlas (TCGA) database revealed NUAK1 and NUAK2 deregulation in lung, breast, liver, ovarian, and melanoma tumors (Figure 1a,b). This evidence concerns the gene NUAK2 and cancer.